Thailand Cancer Diagnostics Market Size & Outlook
Thailand cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Thailand cancer diagnostics market highlights
- The Thailand cancer diagnostics market generated a revenue of USD 548.1 million in 2023 and is expected to reach USD 1,026.8 million by 2030.
- The Thailand market is expected to grow at a CAGR of 9.4% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 548.1 million |
| Market revenue in 2030 | USD 1,026.8 million |
| Growth rate | 9.4% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Thailand accounted for 0.5% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,680.0 million by 2030.
Consumables was the largest segment with a revenue share of 59.88% in 2023. Horizon Databook has segmented the Thailand cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
In Thailand, constant developments in cancer screening have positively impacted the market. For instance, in April 2022, Banphaeo General Hospital collaborated with AstraZeneca Thailand to launch the “Don’t Wait. Get Checked.” campaign, which integrated AI to diagnose early-stage lung cancer. This would create further opportunities in the country’s market.
Several hospitals and laboratories offer tests for diagnosing cancer by using liquid biopsy tests. According to a Thailand Medical News report published in December 2019, new rapid and inexpensive liquid biopsy tests became more prevalent in the medical industry to diagnose patients with cancer. Thus, ease of availability and accessibility to liquid biopsy products in the country is anticipated to drive market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Thailand cancer diagnostics market size, by product, 2018-2030 (US$M)
Thailand Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
